Accuray Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
Accuray Inc Stock Forecast and Price Target
According to experts, who recently provided their 2024 price targets for Accuray Inc, the average price target is $8.00, with a high estimate of $13.00 and a low estimate of $6.00. That is a potential upside of approximately 265.3% from the last closing price of $2.19 on April, 2024. Even if you are not interested in ARAY stock, you should still be aware of its competitors.
265.30% Upside
Accuray Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Accuray Inc's Price has grown by 100.00%, rising from $0.00 to $0.00. For next year, analysts predict Fair Value of $2.23, which would mean an increase of 100.00%. Over the next seven years, experts predict that Accuray Inc's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$107.53 | Buy/Sell | $118.92 | 17.64% |
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$375.33 | Buy/Sell | $408.45 | 14.57% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$73.17 | Buy/Sell | $70.14 | 12.07% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.74 | Buy/Sell | $92.47 | 19.76% |
| DXCM Stock Forecast | DexCom Inc | Buy |
12
|
$124.34 | Buy/Sell | $125.98 | 20.64% |
Accuray Inc Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Accuray Inc's Revenue has grown by 16.89%, rising from $382.93M to $447.61M. For next year, analysts predict Revenue of $463.82M, which would mean an increase of 3.62%. Over the next seven years, experts predict that Accuray Inc's Revenue will grow at a rate of 9.46%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RMD Stock Forecast | ResMed Inc | Outperform |
17
|
$218.06 | Buy/Sell | $201.32 | 0.43% |
| VAR Stock Forecast | Varian Medical Systems | - |
16
|
$176.53 | Buy/Sell | $177.67 | -100.00% |
| SWAV Stock Forecast | Shockwave Medical | Hold |
4
|
$330.00 | Buy/Sell | $239.91 | 1.52% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PODD Stock Forecast | Insulet | Outperform |
15
|
$166.19 | Buy/Sell | $222.05 | 42.01% |
| LVGO Stock Forecast | Livongo Health | - |
0
|
$0.00 | Buy/Sell | $126.17 | 0.00% |
| MASI Stock Forecast | Masimo | Outperform |
14
|
$136.14 | Buy/Sell | $96.33 | 16.13% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INSP Stock Forecast | Inspire Medical Systems | Outperform |
6
|
$237.45 | Buy/Sell | $225.45 | 11.60% |
| ITGR Stock Forecast | Integer Holdings | Outperform |
16
|
$109.58 | Buy/Sell | $95.00 | 18.63% |
| AXNX Stock Forecast | Axonics | Hold |
7
|
$66.69 | Buy/Sell | $70.15 | 6.46% |
Accuray Inc EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Accuray Inc's EBITDA has decreased from $20.08M to $6.91M – a 65.59% drop. In the next year, analysts believe that EBITDA will reach $27.58M – an increase of 299.13%. For the next seven years, experts predict that Accuray Inc's EBITDA will grow at a rate of 405.84%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CMD Stock Forecast | Cantel Medical LLC | - |
17
|
$0.05 | Buy/Sell | $85.00 | -100.00% |
| IRTC Stock Forecast | iRhythm Technologies | Buy |
11
|
$111.91 | Buy/Sell | $126.70 | 20.63% |
| TMDX Stock Forecast | TransMedics Group | Outperform |
8
|
$92.08 | Buy/Sell | $90.00 | 9.69% |
Accuray Inc EBIT Forecast for 2023 - 2025 - 2030
Accuray Inc's EBIT has decreased by 81.02% In the last three years, from $12.54M to $2.38M. In the next year, analysts believe that EBIT will reach $12.09M – an increase of 407.98%. For the next seven years, the forecast is for EBIT to grow by 1036.84%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TNDM Stock Forecast | Tandem Diabetes Care | Outperform |
9
|
$35.24 | Buy/Sell | $30.80 | 3.58% |
| CNMD Stock Forecast | CONMED | Outperform |
16
|
$65.78 | Buy/Sell | $123.38 | 31.50% |
| GNMK Stock Forecast | GenMark Diagnostics | - |
2
|
$0.00 | Buy/Sell | $24.05 | 0.00% |
Accuray Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Accuray Inc's EPS has grown by 100.00%, rising from $-0.06 to $0.00. For next year, analysts predict EPS of $-0.07, which would mean an increase of 100.00%. Over the next seven years, experts predict that Accuray Inc's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NTUS Stock Forecast | Natus Medical | - |
14
|
$32.96 | Buy/Sell | $36.00 | 16.60% |
| QTRX Stock Forecast | Quanterix | Outperform |
11
|
$15.56 | Buy/Sell | $32.00 | 105.66% |
| SLNO Stock Forecast | Soleno Therapeutics | Buy |
0
|
$47.32 | Buy/Sell | $6.00 | 7.78% |
.jpg)